STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
18.16
+0.13 (0.72%)
Apr 28, 2025, 4:00 PM EDT - Market closed
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for STAAR Surgical Company stock have an average target of 30.71, with a low estimate of 16 and a high estimate of 55. The average target predicts an increase of 69.11% from the current stock price of 18.16.
Analyst Consensus: Buy
* Price targets were last updated on Mar 18, 2025.
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Reiterates $17 | Hold | Reiterates | $17 | -6.39% | Mar 18, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 27, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $28 → $17 | Hold | Maintains | $28 → $17 | -6.39% | Feb 13, 2025 |
| Stifel | Stifel | Strong Buy Maintains $38 → $20 | Strong Buy | Maintains | $38 → $20 | +10.13% | Feb 12, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Reiterates $28 | Hold | Reiterates | $28 | +54.19% | Feb 12, 2025 |
Financial Forecast
Revenue This Year
265.96M
from 313.90M
Decreased by -15.27%
Revenue Next Year
334.81M
from 265.96M
Increased by 25.89%
EPS This Year
-0.90
from -0.41
EPS Next Year
0.15
from -0.90
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 295.1M | 413.7M | 373.8M | ||
| Avg | 266.0M | 334.8M | 335.3M | ||
| Low | 237.3M | 267.0M | 307.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -6.0% | 55.6% | 11.6% | ||
| Avg | -15.3% | 25.9% | 0.1% | ||
| Low | -24.4% | 0.4% | -8.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.76 | 0.86 | 0.92 | |
| Avg | -0.90 | 0.15 | 0.19 | |
| Low | -1.02 | -0.57 | -0.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | 534.4% | |
| Avg | - | - | 33.1% | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.